Skip to main content
Top
Published in: Applied Health Economics and Health Policy 3/2013

Open Access 01-06-2013 | Original Research Article

Community-Acquired Pneumonia Episode Costs by Age and Risk in Commercially Insured US Adults Aged ≥50 Years

Authors: Reiko Sato, Gabriel Gomez Rey, Stephanie Nelson, Brett Pinsky

Published in: Applied Health Economics and Health Policy | Issue 3/2013

Login to get access

Abstract

Background

Community-acquired pneumonia (CAP) causes substantial clinical and economic burden. While several studies have reported the cost to treat CAP, there is little information on the cost to treat by age, risk profile, and hospitalization in US adults aged ≥50 years.

Objective

To quantify the cost, from a payer perspective, of treating CAP at the episode level, stratified by age, risk profile, and hospitalization.

Methods

A retrospective study of claims data from a large US health plan (1 January 2006–31 December 2008) was conducted. Patients aged ≥50 years having at least one medical claim with a primary diagnosis for pneumonia were identified. A CAP episode was defined as the period between the first and last pneumonia ICD-9 code with a chest X-ray claim. Episode-level variables included risk stratum based on presence of an immunocompromising/chronic condition, age group, number and length of inpatient and outpatient CAP episodes, and all-cause and CAP-related healthcare costs (adjusted to 2011 costs).

Results

Among the 27,659 study patients, 28,575 CAP episodes (20,454 outpatient; 8,121 inpatient) occurred. Mean age of patients with a CAP episode was 62.6. Low-risk patients accounted for 44.4 % of all CAP episodes. Mean CAP episode length was 31.8 days for an inpatient episode and 10.2 days for an outpatient episode. Mean all-cause total healthcare cost for an inpatient CAP episode ranged from $11,148 to $51,219 depending on risk stratum and age group. Mean outpatient episode-related costs were much lower than inpatient episode-related costs.

Conclusions

Cost to treat CAP requiring hospitalization is high regardless of age or the presence of underlying comorbidities. Given that almost half of the patients in this study did not have traditional risk factors for CAP, it is clear that better preventative strategies are needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference File TM Jr, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgrad Med. 2010;122:130–41.PubMedCrossRef File TM Jr, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgrad Med. 2010;122:130–41.PubMedCrossRef
2.
go back to reference Brar NK, Niederman MS. Management of community-acquired pneumonia: a review and update. Ther Adv Respir Dis. 2011;5:61–78.PubMedCrossRef Brar NK, Niederman MS. Management of community-acquired pneumonia: a review and update. Ther Adv Respir Dis. 2011;5:61–78.PubMedCrossRef
3.
go back to reference Metersky ML, Ma A, Houck PM, et al. Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolones. Chest. 2007;131:466–73.PubMedCrossRef Metersky ML, Ma A, Houck PM, et al. Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolones. Chest. 2007;131:466–73.PubMedCrossRef
4.
go back to reference Marrie TJ, Shariatzadeh MR. Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine (Baltimore). 2007;86:103–11.CrossRef Marrie TJ, Shariatzadeh MR. Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine (Baltimore). 2007;86:103–11.CrossRef
5.
go back to reference Restrepo MI, Mortensen EM, Velez JA, et al. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest. 2008;133:610–7.PubMedCrossRef Restrepo MI, Mortensen EM, Velez JA, et al. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest. 2008;133:610–7.PubMedCrossRef
6.
go back to reference Colice GL, Morley MA, Asche C, et al. Treatment costs of community-acquired pneumonia in an employed population. Chest. 2004;125:2140–5.PubMedCrossRef Colice GL, Morley MA, Asche C, et al. Treatment costs of community-acquired pneumonia in an employed population. Chest. 2004;125:2140–5.PubMedCrossRef
7.
go back to reference Marrie TJ, Huang JQ. Low-risk patients admitted with community-acquired pneumonia. Am J Med. 2005;118:1357–63.PubMedCrossRef Marrie TJ, Huang JQ. Low-risk patients admitted with community-acquired pneumonia. Am J Med. 2005;118:1357–63.PubMedCrossRef
8.
go back to reference McAlister FA, Majundar SR, Blitz S, et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28:810–5.PubMedCrossRef McAlister FA, Majundar SR, Blitz S, et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28:810–5.PubMedCrossRef
9.
go back to reference Ewig S, Woodhead M, Torres A. Towards a sensible comprehension of severe community-acquired pneumonia. Intensive Care Med. 2011;37:214–23.PubMedCrossRef Ewig S, Woodhead M, Torres A. Towards a sensible comprehension of severe community-acquired pneumonia. Intensive Care Med. 2011;37:214–23.PubMedCrossRef
10.
go back to reference Jackson ML, Neuzil KM, Thompson WW, et al. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004;39:1642–50.PubMedCrossRef Jackson ML, Neuzil KM, Thompson WW, et al. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004;39:1642–50.PubMedCrossRef
11.
go back to reference Ramsdell J, Narsavage GL, Fink JB. Management of community-acquired pneumonia in the home. An American College of Chest Physicians Clinical Position Statement. Chest. 2005;127:1752–63.PubMedCrossRef Ramsdell J, Narsavage GL, Fink JB. Management of community-acquired pneumonia in the home. An American College of Chest Physicians Clinical Position Statement. Chest. 2005;127:1752–63.PubMedCrossRef
12.
go back to reference Conte HA, Chen Y-T, Mehal W, et al. A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am J Med. 1999;106:20–8.PubMedCrossRef Conte HA, Chen Y-T, Mehal W, et al. A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am J Med. 1999;106:20–8.PubMedCrossRef
14.
go back to reference Hall MJ, DeFrances CJ, Williams SN, et al. National Hospital Discharge survey: 2007 summary. National Health Statistics Report Hyattsville, MD: National Center for Health Statistics; 2010. p. 1–21. Hall MJ, DeFrances CJ, Williams SN, et al. National Hospital Discharge survey: 2007 summary. National Health Statistics Report Hyattsville, MD: National Center for Health Statistics; 2010. p. 1–21.
15.
go back to reference Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27–72.PubMedCrossRef Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27–72.PubMedCrossRef
16.
go back to reference Yu H, Rubin J, Dunning S, Li S, Sato R. Clinical and economic burden of community acquired pneumonia in the Medicare fee-for-service population. J Am Geriatr Soc. 2012;60:2137–43.PubMed Yu H, Rubin J, Dunning S, Li S, Sato R. Clinical and economic burden of community acquired pneumonia in the Medicare fee-for-service population. J Am Geriatr Soc. 2012;60:2137–43.PubMed
17.
go back to reference Bonafede MM, Suava JA, Wilson KL, Mannino DM, Polsky D. Incidence and cost of CAP in a large working-age population. Am J Manag Care. 2012;18:380–7.PubMed Bonafede MM, Suava JA, Wilson KL, Mannino DM, Polsky D. Incidence and cost of CAP in a large working-age population. Am J Manag Care. 2012;18:380–7.PubMed
18.
go back to reference Martin AB, Lassman D, Washington B, Catlin A, the National Healthcare Expenditure Accounts Team. Growth in US health spending remained slow in 2010; health share of gross domestic product was unchanged from 2009. Health Aff. 2012;31:1208–19.CrossRef Martin AB, Lassman D, Washington B, Catlin A, the National Healthcare Expenditure Accounts Team. Growth in US health spending remained slow in 2010; health share of gross domestic product was unchanged from 2009. Health Aff. 2012;31:1208–19.CrossRef
19.
go back to reference Restrepo MI, Frei CR. Health economics of use of fluoroquinolones to treat patients with community-acquired pneumonia. Am J Med. 2010;123:S39–48.PubMedCrossRef Restrepo MI, Frei CR. Health economics of use of fluoroquinolones to treat patients with community-acquired pneumonia. Am J Med. 2010;123:S39–48.PubMedCrossRef
20.
go back to reference Sun HK, Nicolau DP, Kuti JL. Resource utilization of adults admitted to a large urban hospital with community-acquired pneumonia caused by Streptococcus pneumoniae. Chest. 2006;130:807–14.PubMedCrossRef Sun HK, Nicolau DP, Kuti JL. Resource utilization of adults admitted to a large urban hospital with community-acquired pneumonia caused by Streptococcus pneumoniae. Chest. 2006;130:807–14.PubMedCrossRef
21.
go back to reference Orrick JJ, Segal R, Johns TE, et al. Resource use and cost of care for patients hospitalized with community-acquired pneumonia: impact of adherence to Infectious Diseases Society of American guidelines. Pharmacoeconomics. 2004;22:751–7.PubMedCrossRef Orrick JJ, Segal R, Johns TE, et al. Resource use and cost of care for patients hospitalized with community-acquired pneumonia: impact of adherence to Infectious Diseases Society of American guidelines. Pharmacoeconomics. 2004;22:751–7.PubMedCrossRef
22.
go back to reference Restrepo MI, Mortensen EM, Rello J, Brody J, Anzueto A. Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest. 2010;137:552–7.PubMedCentralPubMedCrossRef Restrepo MI, Mortensen EM, Rello J, Brody J, Anzueto A. Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest. 2010;137:552–7.PubMedCentralPubMedCrossRef
23.
go back to reference Lindenauer PK, Bernheim SM, Grady NJ, et al. The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for Medicare beneficiaries with pneumonia. J Hosp Med. 2010;5:E13–8.CrossRef Lindenauer PK, Bernheim SM, Grady NJ, et al. The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for Medicare beneficiaries with pneumonia. J Hosp Med. 2010;5:E13–8.CrossRef
24.
go back to reference US Department of Labor. Consumer Price Index. Chained Consumer Price Index for all urban consumers (C-CPI-U) 1999–2008. Medical Care Series ID: SUUR0000SAM. Washington, DC: U.S. Dept. of Labor, Bureau of Labor Statistics; 2008. US Department of Labor. Consumer Price Index. Chained Consumer Price Index for all urban consumers (C-CPI-U) 1999–2008. Medical Care Series ID: SUUR0000SAM. Washington, DC: U.S. Dept. of Labor, Bureau of Labor Statistics; 2008.
25.
go back to reference Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1997;46:1–24. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1997;46:1–24.
26.
go back to reference Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep. 2010;59:1102–6. Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep. 2010;59:1102–6.
27.
go back to reference Kaplan V, Angus DC, Griffin M, et al. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002;165:766–72.PubMedCrossRef Kaplan V, Angus DC, Griffin M, et al. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002;165:766–72.PubMedCrossRef
28.
go back to reference DeFrances CJ, Lucas CA, Bule VC, et al. 2006 National Hospital Discharge Survey. Natl Health Stat Rep. 2008;30:1–20. DeFrances CJ, Lucas CA, Bule VC, et al. 2006 National Hospital Discharge Survey. Natl Health Stat Rep. 2008;30:1–20.
29.
go back to reference Metlay JP, Fine MJ, Schulz R, et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J Gen Intern Med. 1997;12:423–30.PubMedCentralPubMedCrossRef Metlay JP, Fine MJ, Schulz R, et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J Gen Intern Med. 1997;12:423–30.PubMedCentralPubMedCrossRef
Metadata
Title
Community-Acquired Pneumonia Episode Costs by Age and Risk in Commercially Insured US Adults Aged ≥50 Years
Authors
Reiko Sato
Gabriel Gomez Rey
Stephanie Nelson
Brett Pinsky
Publication date
01-06-2013
Publisher
Springer International Publishing
Published in
Applied Health Economics and Health Policy / Issue 3/2013
Print ISSN: 1175-5652
Electronic ISSN: 1179-1896
DOI
https://doi.org/10.1007/s40258-013-0026-0

Other articles of this Issue 3/2013

Applied Health Economics and Health Policy 3/2013 Go to the issue